» Articles » PMID: 30424519

Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2018 Nov 15
PMID 30424519
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ricin, a highly lethal toxin derived from the seeds of (castor beans) is considered a potential biological threat agent due to its high availability, ease of production, and to the lack of any approved medical countermeasure against ricin exposures. To date, the use of neutralizing antibodies is the most promising post-exposure treatment for ricin intoxication. The aim of this work was to generate anti-ricin antitoxin that confers high level post-exposure protection against ricin challenge. Due to safety issues regarding the usage of ricin holotoxin as an antigen, we generated an inactivated toxin that would reduce health risks for both the immunizer and the immunized animal. To this end, a monomerized ricin antigen was constructed by reducing highly purified ricin to its monomeric constituents. Preliminary immunizing experiments in rabbits indicated that this monomerized antigen is as effective as the native toxin in terms of neutralizing antibody elicitation and protection of mice against lethal ricin challenges. Characterization of the monomerized antigen demonstrated that the irreversibly detached A and B subunits retain catalytic and lectin activity, respectively, implying that the monomerization process did not significantly affect their overall structure. Toxicity studies revealed that the monomerized ricin displayed a 250-fold decreased activity in a cell culture-based functionality test, while clinical signs were undetectable in mice injected with this antigen. Immunization of a horse with the monomerized toxin was highly effective in elicitation of high titers of neutralizing antibodies. Due to the increased potential of IgG-derived adverse events, anti-ricin F(ab')₂ antitoxin was produced. The F(ab')₂-based antitoxin conferred high protection to intranasally ricin-intoxicated mice; ~60% and ~34% survival, when administered 24 and 48 h post exposure to a lethal dose, respectively. In line with the enhanced protection, anti-inflammatory and anti-edematous effects were measured in the antitoxin treated mice, in comparison to mice that were intoxicated but not treated. Accordingly, this anti-ricin preparation is an excellent candidate for post exposure treatment of ricin intoxications.

Citing Articles

A Monoclonal Antibody with a High Affinity for Ricin Isoforms D and E Provides Strong Protection against Ricin Poisoning.

Lequesne L, Dano J, Rouaix A, Kropp C, Plaisance M, Gelhaye S Toxins (Basel). 2024; 16(10).

PMID: 39453188 PMC: 11510859. DOI: 10.3390/toxins16100412.


Long-Term Pulmonary Damage in Surviving Antitoxin-Treated Mice following a Lethal Ricin Intoxication.

Gal Y, Sapoznikov A, Lazar S, Shoseyov D, Aftalion M, Gutman H Toxins (Basel). 2024; 16(2).

PMID: 38393180 PMC: 10892648. DOI: 10.3390/toxins16020103.


Comparative Aspects of Ricin Toxicity by Inhalation.

Stoll A, Shenton D, Green A, Holley J Toxins (Basel). 2023; 15(4).

PMID: 37104219 PMC: 10145923. DOI: 10.3390/toxins15040281.


Rapid, Sensitive and Reliable Ricin Identification in Serum Samples Using LC-MS/MS.

Feldberg L, Elhanany E, Laskar O, Schuster O Toxins (Basel). 2021; 13(2).

PMID: 33499033 PMC: 7911523. DOI: 10.3390/toxins13020079.


Post-Exposure Anti-Ricin Treatment Protects Swine Against Lethal Systemic and Pulmonary Exposures.

Falach R, Sapoznikov A, Evgy Y, Aftalion M, Makovitzki A, Agami A Toxins (Basel). 2020; 12(6).

PMID: 32481526 PMC: 7354453. DOI: 10.3390/toxins12060354.


References
1.
Greenfield R, Brown B, Hutchins J, Iandolo J, Jackson R, Slater L . Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002; 323(6):326-40. DOI: 10.1097/00000441-200206000-00005. View

2.
Lu L, Suscovich T, Fortune S, Alter G . Beyond binding: antibody effector functions in infectious diseases. Nat Rev Immunol. 2017; 18(1):46-61. PMC: 6369690. DOI: 10.1038/nri.2017.106. View

3.
Komaki Y, Sugiura H, Koarai A, Tomaki M, Ogawa H, Akita T . Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways. Pulm Pharmacol Ther. 2005; 18(4):297-302. DOI: 10.1016/j.pupt.2005.01.002. View

4.
Olsnes S, Kozlov J . Ricin. Toxicon. 2001; 39(11):1723-8. DOI: 10.1016/s0041-0101(01)00158-1. View

5.
OHara J, Brey 3rd R, Mantis N . Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice. Clin Vaccine Immunol. 2013; 20(6):789-94. PMC: 3675979. DOI: 10.1128/CVI.00098-13. View